FDA Inspection 1207942 — Reproductive Endocrine Center Sperm Physiology Lab
The FDA completed an inspection of Reproductive Endocrine Center Sperm Physiology Lab on June 8, 2023 in Orange, CT. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 8, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Orange, CT (United States)